American depository receipts of European stocks were 0.2% higher at 124.27 on the Bank of New York Mellon Europe ADR Index on Monday morning.
Gainers in Continental Europe were led by Natuzzi (NTZ), an Italian furniture manufacturer, 3.9% higher, followed by Cellectis (CLLS), a French genome engineering company, up by 3.0% and STMicroelectronics – New York Shares (STM), an Italian semiconductor company, 2.9% higher. Telecom Italia – Savings (STM), an Italian telecommunications company, was up by 2.8%.
In the UK, Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was 3.8% higher, followed by Midatech Pharma (MTP), an early-stage biopharmaceutical company, up by 2.5% and CRH (CRH), a building materials company, 2.1% higher. Avadel (AVDL), a specialty pharmaceutical company, was up by 1.6%.
Decliners in Continental Europe were led by Sequans Communications (SQNS), a French developer of chipset solutions, 3.4% lower, followed by Edap (EDAP), a French medical devices developer, down by 2.1% and Talend (TLND), a provider of open source integration solutions, 2.0% lower. Nabriva Therapeutics (NBRV), an Austria-based clinical-stage biopharmaceutical company, was 1.7% lower.
And, in the UK, high street bank Barclays Bank Series 5 – Pref (BCS PR D) was 1.5% lower, followed by telecommunications company Vodafone (VOD) and Smith & Nephew (SNN), a medical devices business, both 1.4% lower and BT Group (BT), a communications services company, down by 0.9%.